Chronic Lymphocytic Leukemia News and Research

RSS
Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The disease arises in lymphocytes, a type of white blood cell that normally produces antibodies and serves important immune functions.
FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

FDA researchers find underrepresentation of adults aged 75 years and older in blood cancer clinical trials

Study: Combination targeted therapy has high response rates in AML patients

Study: Combination targeted therapy has high response rates in AML patients

Combination of chemotherapy and targeted drug improves response in younger CLL patients

Combination of chemotherapy and targeted drug improves response in younger CLL patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

Study: Cancer patients willing to swap drug efficacy for reduced risk of adverse events

Study: Cancer patients willing to swap drug efficacy for reduced risk of adverse events

Penn researchers provide new insights into how Notch drives growth of B-cell cancers

Penn researchers provide new insights into how Notch drives growth of B-cell cancers

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

Tattoo ink from 15 years ago mimics lymph node cancer: Case study

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

UC San Diego researchers receive $18.2 million grant for B cell cancer clinical trial

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

FDA gives its nod to new drug Imbruvica (Ibrutinib) for chronic Graft versus Host Disease

Shaping the future of oncology treatment

Shaping the future of oncology treatment

New approach may improve translation of immunological research findings

New approach may improve translation of immunological research findings

New analysis compares emerging algorithms that look for cancer mutations

New analysis compares emerging algorithms that look for cancer mutations

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Adding new antibody to chemotherapy could bolster effects of cancer treatment

Adding new antibody to chemotherapy could bolster effects of cancer treatment

New findings highlight possibility of developing specific cancer drugs with fewer side effects

New findings highlight possibility of developing specific cancer drugs with fewer side effects

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Cancer drug may help treat food allergies

Cancer drug may help treat food allergies

WHO to launch pilot project for prequalifying biosimilar cancer medicines

WHO to launch pilot project for prequalifying biosimilar cancer medicines

Scientists announce ‘outstanding’ results of new blood cancer study

Scientists announce ‘outstanding’ results of new blood cancer study